Use of 5-alpha reductase inhibitors is associated with delayed diagnosis and higher mortality in men who develop prostate…
Read more
Lenalidomide cuts the risk of smouldering multiple myeloma progressing to overt cancer, a randomised controlled phase II/III…
Read more
Most teens and young adults with cancer want a voice in how their tumours are treated, but almost one in four express regret…
Read more
A patient with a non-malignant bowel lesion who died after an unnecessary right hemicolectomy did not even realise the…
Read more
sponsored
This survey is produced and distributed by Australian Doctor Group on behalf of Leo Pharma. Australian Doctor wants to hear…
Read more
One-third of cancer patients use complementary or alternative medicine (CAM) and about one in four fail to tell their…
Read more
Patients with relapsed or refractory indolent non-Hodgkin lymphoma enjoy two years of progression-free survival when…
Read more
Forty-one per cent of cancers detected by PSA screening can be classed as overdiagnosis, researchers say. Overdiagnosis of…
Read more